论文部分内容阅读
目的进一步探讨原发性肝癌介入治疗的远期疗效及影响因素。方法对2001年8月至2007年5月来我院就诊的78例行介入治疗的原发性肝癌患者进行随访和回顾性分析,对影响肝癌治疗的相关因素进行探讨。结果肝癌介入治疗的疗效与患者的年龄、身体状况、脏器功能情况以及肿瘤的形态学特征和血供密切相关,所以根据患者以上情况,选择介入治疗的合理时机、熟练的导管技术非常重要。结论介入化疗栓塞治疗原发性肝癌疗效肯定,延长了病人生存期,但尚有一些问题需进一步探讨。
Objective To further explore the long-term efficacy and influencing factors of primary liver cancer interventional therapy. Methods A total of 78 patients with primary liver cancer undergoing PCI from August 2001 to May 2007 were followed up and retrospectively analyzed. The related factors affecting the treatment of liver cancer were discussed. Results The efficacy of interventional therapy for liver cancer was closely related to the patient’s age, physical condition, organ function, tumor morphology and blood supply. Therefore, according to the above situation, it is very important to select the appropriate timing of interventional therapy and skilled catheterization. Conclusion The interventional chemoembolization for the treatment of primary hepatocellular carcinoma is effective and prolongs the survival of patients. However, there are still some problems to be further explored.